Procurement Summary
Country : Czech Republic
Summary : The active substances of KEYTRUDA 25 mg / ml inf., 50mg in 1 lag.inf. with a content of Pembrolizumab 25 mg in 1ml, or 50mg in 1lag.
Deadline : 02 Dec 2019
Other Information
Notice Type : Tender
TOT Ref.No.: 38126527
Document Ref. No. : VZ0081546
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : UNIVERSITY HOSPITAL OSTRAVA
17. listopadu 1790/5, 708 52 Ostrava - Poruba, Czech Republic
Phone: +420 597 371 1111
Czech Republic
Email :fno@fno.cz
URL :www.fno.cz
Tender Details
Tender invited for The active substances of KEYTRUDA 25 mg / ml inf., 50mg in 1 lag.inf. with a content of Pembrolizumab 25 mg in 1ml, or 50mg in 1lag.
Brief Description : The Subject Of Fulfillment Are Continuous And Repeated Deliveries Of The Medicinal Product Keytruda With Content Substance Pembrolizumab From Atc Group L01xc18. Individual Deliveries Will Be Realized On The Basis Of Partial Orders Of The Client - Pharmacy Fn Ostrava.
Registration Order Number : Z2016-003695
System Number : P19V00165991
Internal Number : DNS-01/16-VZ-70/19
Dead Line : 02/12/2019
Contact Person
Name and surname: Petra Plevova
Job position: officer, dept. commercial-law
Telephone: 420 597 373 080
Mobile phone:
Fax: +420 596 916 056
Email: petra.plevova@fno.cz
Documents
Tender Notice